glp-1 drug mounjaro FDA approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price GLP-1 SOS™ Digestive Support for

5 December 2017

Many of these drugs feature novel mechanisms of action or routes of administration and this increased competition may eventually exert downward pressure on pricing

DOI: Published online: May 1, 2025 1 Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea 2 Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea Corresponding author: Jae Hyun Bae Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea E-mail: [email protected] Copyright 2025 Korean Diabetes Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited

They go by the names of Ozempic, Mounjaro, and Trulicity those are the best-selling GLP-1 drugs, accounting for 70% of sales in 2023

The Oxford 2011 levels of evidence

2024, p